Skip to content

Cannabis: all studies

Page 46 of 289: studies 451 to 460 of 2,882, newest first. Back to the cannabis overview

Research

Associations between regular cannabis use and brain resting-state functional connectivity in adolescents and adults

Journal of Psychopharmacology July 29, 2023 Natalie Ertl, Will Lawn, Claire Mokrysz et al. 17 citations

BACKGROUND/AIM: Cannabis use is highly prevalent in adolescents; however, little is known about its effects on adolescent brain function. METHOD: = 70, 35 adolescents/35 adults). Pre-registered analyses examined the connectivity of seven major cortical and sub-cortical brain networks (default mode network, executive control network (ECN), salience network, hippocampal network and three striatal...

Potency and safety analysis of hemp delta-9 products: the hemp vs. cannabis demarcation problem

Journal of Cannabis Research July 26, 2023 Lee Johnson, Marc Malone, Erik R. Paulson et al.

Background Hemp-derived delta-9 tetrahydrocannabinol (∆^9 THC) products are freely available for sale across much of the USA, but the federal legislation allowing their sale places only minimal requirements on companies. Products must contain no more than 0.3% ∆^9 THC by dry weight, but no limit is placed on overall dosage and there is no requirement that products are tested. However, some...

Daily Cannabidiol Administration for 10 Weeks Modulates Hippocampal and Amygdalar Resting-State Functional Connectivity in Cannabis Users: A Functional Magnetic Resonance Imaging Open-Label Clinical Trial

Cannabis and Cannabinoid Research July 26, 2023 Valentina Lorenzetti, Eugene McTavish, Samantha J Broyd et al.

Introduction: Cannabis use is associated with brain functional changes in regions implicated in prominent neuroscientific theories of addiction. Emerging evidence suggests that cannabidiol (CBD) is neuroprotective and may reverse structural brain changes associated with prolonged heavy cannabis use. In this study, we examine how an ∼10-week exposure of CBD in cannabis users affected...

Hippocampal differential expression underlying the neuroprotective effect of delta-9-tetrahydrocannabinol microdose on old mice.

Frontiers in Neuroscience July 18, 2023 Guy Shapira, Ifat Israel-Elgali, Meitar Grad et al.

Delta-9-tetrahydrocannabinol (THC) is the primary psychoactive compound of the cannabis plant and an exogenous ligand of the endocannabinoid system. In previous studies, we demonstrated that a single microdose of THC (0.002 mg/kg, 3-4 orders of magnitude lower than the standard dose for rodents) exerts distinct, long-term neuroprotection in model mice subjected to acute neurological insults....

Running High: Cannabis Users' Subjective Experience of Exercise During Legal Market Cannabis Use Versus No Use in a Naturalistic Setting

Cannabis and Cannabinoid Research July 13, 2023 Laurel P Gibson, Angela D Bryan

Background: The use of cannabis with various forms of exercise (e.g., running) has received increased media attention in recent years, contradicting the popular stereotype that cannabis is associated with sedentary behavior. Although cross-sectional evidence suggests a positive association between cannabis use and exercise engagement, to date, the acute effects of cannabis on exercise remain...

Neurotoxic or Protective Cannabis Components: Delta-9-Tetrahydrocannabinol ( Δ9 THC) and Cannabidiol (CBD)

Journal of Exploratory Research in Pharmacology July 12, 2023 Marilyn Helen Silva 1 citation

Cannabis sativa contains phytocannabinoids that are psychoactive and neurotoxic (delta-9-tetrahydrocannabinol: Δ9THC) or nonpsychoactive and presumptively neuroprotective (cannabidiol: CBD). Along with rising legalization, availability, and demand, the Δ9THC:CBD ratio also has increased. Cannabis legalization means that use will likely increase in pregnant or breastfeeding women, affecting all...

Recommendations for Reducing the Risk of Cannabis Use-Related Adverse Psychosis Outcomes: A Public Mental Health-Oriented Evidence Review

Journal of dual diagnosis July 3, 2023 Benedikt Fischer, W. Hall, T. Fidalgo et al.

Abstract Objective: Cannabis use is increasingly normalized; psychosis is a major adverse health outcome. We reviewed evidence on cannabis use-related risk factors for psychosis outcomes at different stages toward recommendations for risk reduction by individuals involved in cannabis use. Methods: We searched primary databases for pertinent literature/data 2016 onward, principally relying on...

Self-reported THC content and associations with perceptions of feeling high among cannabis consumers.

Drug and Alcohol Review July 2023 Jesse Lineham, Elle Wadsworth, David Hammond

Few studies have examined consumer knowledge and communication of tetrahydrocannabinol (THC) content among cannabis consumers, including potential differences by cannabis legislation. The study sought to: (i) examine self-reported knowledge of THC content across 10 cannabis products; (ii) examine self-reported intoxication levels; and (iii) examine association between self-reported THC levels...

Daily Δ9-Tetrahydrocannabinol and Withdrawal Increase Dopamine D1-D2 Receptor Heteromer to Mediate Anhedonia- and Anxiogenic-like Behavior Through a Dynorphin and Kappa Opioid Receptor Mechanism.

Biological Psychiatry Global Open Science July 2023 Ahmed Hasbi, Bertha K. Madras, Susan R George

Frequent cannabis use is associated with a higher risk of developing cannabis use disorder and other adverse consequences. However, rodent models studying the underlying mechanisms of the reinforcing and withdrawal effects of the primary constituent of cannabis, Δ9-tetrahydrocannabinol (THC), have been limited. This study investigated the effects of daily THC (1 mg/kg, intraperitoneal, 9 days)...

Moon Rock Cannabis-Induced Psychosis and New-Onset Seizures in a 20-Year-Old Male

Cureus July 1, 2023 Martin Leczycki, P. Zaki, Eduardo D. Espiridion

“Moon rock” cannabis is a type of new and highly potent preparation of cannabis, which is made of a strain of cannabis dipped in hash oil and sprinkled with kief crystals, effectively increasing the concentration of δ-9-tetrahydrocannabinol (THC), the main psychoactive compound in cannabis, well beyond what is naturally found in the cannabis plant. The use of increasingly potent forms of...